MILWAUKEE, July 8, 2024 /PRNewswire/ — Ademi LLP is investigating Morphic (NASDAQ: MORF) for possible breaches of fiduciary duty and other violations of law in its transaction with Lilly. Click here to learn how to join our investigation…
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.